BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Cytovance Biologics Inc. Selected For GMP Manufacture Of AM0010 For ARMO BioSciences

  June 23, 2014

   · 

  2 min read
• BioMidwest

  MicroBiome Therapeutics LLC’ NM504 Improves Blood Glucose Control In Diabetes And Prediabetes

  June 23, 2014

   · 

  4 min read
• Deals

  Shire plc Release: Management Spurns Three Offers From AbbVie , Fighting For Irish Independence, Call Monday Morning

  June 23, 2014

   · 

  1 min read
• Business

  N8 Respiratory Hires Industry Leader As Chief Operating Officer

  June 23, 2014

   · 

  1 min read
• Drug Development

  Triphase Accelerator Announces Orphan Drug Designation In The European Union For Marizomib For Multiple Myeloma

  June 23, 2014

   · 

  1 min read
• Business

  ProBioGen AG Signs GlymaxX ADCC Enhancement Technology License Deal

  June 23, 2014

   · 

  3 min read
• BioMidwest

  Data Presented At ICE/ENDO 2014 Shows MicroBiome Therapeutics LLC’ NM504 Improves Blood Glucose Control In Diabetes And Prediabetes

  June 23, 2014

   · 

  4 min read
• BioMidwest

  EndoShape Scores $6.8 Million For Vascular Plugs And Coils

  June 23, 2014

   · 

  1 min read
• Drug Development

  XenoPort, Inc. Announces Initiation Of A Phase 2 Clinical Trial Of XP23829 In Patients With Psoriasis

  June 23, 2014

   · 

  1 min read
• Deals

  AbbVie Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share

  June 23, 2014

   · 

  3 min read